Ginkgo Bioworks Holdings Inc (DNA) PT Lowered to $11.50 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts DNA Hot Sheet
Price: $11.45 -7.74%
Rating Summary:
3 Buy, 3 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 66
Rating Summary:
3 Buy, 3 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 66
Join SI Premium – FREE
Raymond James analyst Rahul Sarugaser lowered the price target on Ginkgo Bioworks Holdings Inc (NYSE: DNA) to $11.50 (from $14.50) while maintaining a Outperform rating.
You May Also Be Interested In
- Increasing unusual option volume: INDA GMAB PACB RMD XP DNA UNM LION EXC
- Lear (LEA) PT Lowered to $132 at UBS
- Lazard (LAZ) PT Lowered to $40 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
